Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+26.0%
5Y CAGR+21.5%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+26.0%/yr
vs +57.8%/yr prior
5Y CAGR
+21.5%/yr
Recent acceleration
Acceleration
-31.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.39B | +21.5% |
| 2024 | $1.14B | +48.9% |
| 2023 | $765.55M | +10.6% |
| 2022 | $691.94M | -2.6% |
| 2021 | $710.15M | +35.9% |
| 2020 | $522.50M | +49.4% |
| 2019 | $349.85M | +213.5% |
| 2018 | $111.61M | +7.3% |
| 2017 | $104.02M | -18.8% |
| 2016 | $128.18M | - |